MindMed, a company focused on turning psychedelics into medicine, is working on a new substance to shut down hallucinations.
While trying to understand what makes the psychedelic drug LSD work, Dr. Mattias Liechti, head of the Liechti Laboratory at the University of Basel Hospital, stumbled onto something unexpected. During his research, he found a substance that seemed to abort the hallucinogenic effects of LSD within 20 to 30 minutes.
Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company